Endotracheal Biopsy

An endotracheal biopsy is a procedure in which a doctor removes a small piece of tissue from the inside lining of the trachea (windpipe), usually during a bronchoscopy. The sample is sent to a pathologist who examines it under the microscope to look for cancer, precancerous changes, infection, or other abnormalities.

Origin

"Endotracheal" combines the Greek endo (within) and trachea (windpipe). "Biopsy" comes from the Greek bios (life) and opsis (view), meaning to view living tissue. The technique became routine after the flexible fiberoptic bronchoscope was introduced by Shigeto Ikeda in 1966.

Significance in Asbestos Context

For people with suspected asbestos-related disease, an endotracheal biopsy is one of several tissue-sampling tools used to reach a firm diagnosis. It is less common than pleural biopsy or transbronchial lung biopsy, but it may be performed when a bronchoscopy reveals a visible abnormality in the trachea itself, for example, a tumor invading the airway or a suspicious lesion that could represent lung cancer extending centrally. The tissue is examined with standard histology and, when appropriate, immunohistochemical stains that help distinguish mesothelioma from lung adenocarcinoma, squamous cell carcinoma, or metastatic disease.

The resulting pathology report is often the single most important document in both your medical care and any legal claim. It establishes exactly what type of cancer you have, which directly affects treatment, prognosis, and eligibility for asbestos trust funds and lawsuits. Because the trachea is a small target and biopsies from it can yield limited tissue, ask whether enough material was obtained for the full panel of stains needed, especially if mesothelioma is on the differential. If the diagnosis is unclear, a larger or different type of biopsy may be needed before treatment decisions are made.

Example Sentence

When the bronchoscopy showed a mass narrowing her upper airway, the pulmonologist performed an endotracheal biopsy, and the pathology report confirmed non-small cell lung cancer in a patient with a documented history of shipyard asbestos exposure.

Related Terms

Bronchoscopy, Endobronchial Biopsy, Pleural Biopsy, Histopathology, Immunohistochemistry, Pathology Report, Transthoracic Needle Biopsy

Notes

• Request copies of the pathology report, the operative/bronchoscopy report, and confirmation that the tissue blocks and slides are being preserved by the hospital. These materials are needed for treatment second opinions and for any trust claim or lawsuit.
• If mesothelioma is suspected, ask whether the pathologist used an immunohistochemical panel (for example, calretinin, WT-1, CK5/6, BAP1, claudin-4, TTF-1) and whether enough tissue remains for additional staining or expert review.
• Consider having the slides reviewed by a mesothelioma-experienced pathologist; misclassification between mesothelioma and adenocarcinoma is well documented and directly affects both treatment and legal eligibility.
• If the biopsy is non-diagnostic or shows only inflammation, ask whether a repeat bronchoscopy, CT-guided needle biopsy, EBUS-guided biopsy, or surgical (VATS) biopsy would give a more definitive answer before starting treatment.
• Document your full occupational and environmental asbestos exposure history with your physician so it is recorded in the same chart as the biopsy result. This linkage strengthens both clinical reasoning and later claims.